封面
市场调查报告书
商品编码
1593521

乳房重建市场规模、份额和成长分析(按产品、按程序、按类型、最终用户、按地区):产业预测(2024-2031)

Breast Reconstruction Market Size, Share, Growth Analysis, By Product (Breast Implant, Tissue Expander), By Procedure (Immediate Procedures, Delayed Procedures), By Type, By End Use, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 155 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球乳房重建市场规模约为5.491亿美元,预计将从2023年的5.864亿美元增加至2031年的9.926亿美元,2017年的复合年增长率为6.8。

由于乳癌发病率上升和支持性报销政策,全球乳房重建市场正在显着增长。由于技术进步和乳房重建手术的增加,市场前景仍然乐观。特别是,医疗保险可以报销乳癌乳房切除术后的乳房重建手术,澳洲服务局根据外部乳房人工替代物报销计画报销乳房人工替代物。这些支持措施预计将进一步增强市场动态。主要参与企业正在积极回应,透过推出创新产品、推出意识计划和扩大地理覆盖范围来满足日益增长的乳房重建需求。乳房重建意识日由整形外科基金会和美国整形外科医生协会于 2023 年 10 月主办,旨在传播重要讯息并提高被诊断患有乳癌的女性对乳房重建方案的认识。同样,2021 年 10 月,Sientra, Inc. 与 Mission Plastico 合作推出了「重塑生活」计画:为贫困女性提供免费的乳房切除后乳房重建服务,这是一项旨在实现的慈善活动。随着这些努力的持续,由于患者需求的增加和乳癌倖存者资源的增加,乳房重建市场有望显着成长。

目录

介绍

  • 分析目的
  • 定义
  • 市场范围

分析方法

  • 资讯采购
  • 二手资料来源和主要资料来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况及展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 创新矩阵
  • 市场生态系统
  • 监管环境
  • 技术分析
  • 专利分析
  • PESTEL分析
  • 市场魅力指数(2023)

乳房重建市场:副产品

  • 市场概况
  • 乳房植入
    • 硅胶植入
    • 圆形的
    • 解剖学的
    • 生理食盐水植入
    • 圆形的
    • 解剖学的
  • 组织扩张器
    • 生理食盐水扩张器
    • 气动组织扩张器
  • 去细胞真皮基材

乳房重建市场:依程序分类

  • 市场概况
  • 同步重组治疗
  • 延迟重组治疗
  • 再植手术

乳房重建市场:依类型

  • 市场概况
  • 单侧乳房重建
  • 两个乳房

乳房重建市场:依最终用户分类

  • 市场概况
  • 医院/诊所
  • 门诊手术中心
  • 其他的

乳房重建市场:按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲 (MEA)
    • 波湾合作理事会(GCC) 国家
    • 南非
    • 其他中东/非洲

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率(2023年)

主要企业简介

  • 强生公司(美国)
  • 艾尔建美学 (AbbVie)(美国)
  • Ideal Implant 公司(美国)
  • 赛宾(法国)
  • GC美学(爱尔兰)
  • POLYTECH 健康与美容(德国)
  • 西恩特拉(美国)
  • Integra生命科学公司(美国)
  • RTI Surgical Holdings(美国)
  • 建立实验室 SA(美国)
  • 西利梅德(巴西)
  • Arion实验室(法国)
  • 广州万和塑胶原料有限公司 (中国)
  • CEREPLAS(法国)
  • 汉斯生物医学(韩国)
  • PMT公司(美国)
  • 上海康宁医疗器材(中国)
  • 贝德米斯(美国)
  • Surgiform 科技有限公司(美国)
  • Motiva 植体(哥斯大黎加)
简介目录
Product Code: SQMIG35A2947

Global Breast Reconstruction Market size was valued at around USD 549.1 Million in 2022 and is expected to rise from USD 586.4 Million in 2023 to reach a value of USD 992.6 Million by 2031, at a CAGR of 6.8% over the forecast period (2024-2031).

The Global Breast Reconstruction market is experiencing significant growth driven by the rising incidence of breast cancer and supportive reimbursement policies. With technical advancements and an increasing number of breast reconstruction surgeries, the market outlook remains positive. Notably, Medicare provides reimbursement for breast reconstruction surgeries following mastectomies due to breast cancer, while Services Australia offers compensation for breast prostheses under its external breast prosthesis reimbursement scheme. These supportive initiatives are expected to enhance market dynamics further. Major industry players are actively responding by launching innovative products, rolling out awareness programs, and expanding their geographical reach to meet the surging demand for breast reconstruction. A prime example includes the Breast Reconstruction Awareness Day initiative organized by The Plastic Surgery Foundation and The American Society of Plastic Surgeons in October 2023, which aimed to raise awareness and disseminate vital information about breast reconstruction options for women diagnosed with breast cancer. Similarly, in October 2021, Sientra, Inc. collaborated with Mission Plasticos to launch "Reshaping Lives: Full Circle," a philanthropic initiative aimed at providing free post-mastectomy breast reconstruction services for underprivileged women. As these efforts continue, the Breast Reconstruction market is poised for substantial growth, fueled by both increasing patient needs and enhanced resource availability for breast cancer survivors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Reconstruction market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Reconstruction Market Segmental Analysis

Global Breast Reconstruction Market is segmented by Product, Procedure, Type, End User, and region. Based on Product, the market is segmented into Breast Implant (Silicone Implants, Saline Implants), Tissue Expander (Saline Tissue Expander, Air Tissue Expander), Acellular Dermal Matrix. Based on Procedure, the market is segmented into Immediate Procedures, Delayed Procedures, Revision Procedures. Based on Type, the market is segmented into Unilateral Breast Reconstruction, and Bilateral. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Breast Reconstruction Market

A significant market driver for the global breast reconstruction market is the heightened focus on aesthetic outcomes following surgeries such as mastectomies. As awareness among patients of the advantages and availability of reconstructive surgery increases, so does demand. Advances in surgical techniques have made breast reconstruction more acceptable and accessible, bolstered by media campaigns and educational initiatives. The rising incidence of breast cancer further intensifies the need for such reconstructive options. Moreover, societal acceptance of cosmetic improvements fuels this growth, as patients increasingly seek not only health restoration but also enhanced physical appearance, positioning breast reconstruction as a critical component of post-cancer care.

Restraints in the Global Breast Reconstruction Market

The Global Breast Reconstruction market faces significant restraint due to the high costs associated with surgeries and advanced implants. Patients often encounter financial hurdles, as insurance coverage for reconstructive procedures is frequently limited or nonexistent, making it challenging for many to afford pre-operative consultations, surgical interventions, and post-operative care. This financial strain can lead to delayed procedures, adversely impacting market growth. Furthermore, regional economic disparities exacerbate access issues, restricting availability for lower-income populations and limiting the market's potential to expand into diverse socio-economic segments. Hence, the financial landscape serves as a formidable barrier to wider market penetration.

Market Trends of the Global Breast Reconstruction Market

The Global Breast Reconstruction market is witnessing a significant shift towards less invasive techniques, driven by advancements in surgical technologies and growing patient preferences for procedures that minimize recovery time and scarring. Techniques such as autologous fat grafting and endoscopic-assisted breast reconstruction are increasingly gaining popularity due to their aesthetic advantages, reduced post-operative discomfort, and quicker rehabilitation, enhancing overall patient satisfaction. As technology continues to evolve, these minimally invasive approaches are poised to reshape the future landscape of breast reconstruction, leading to improved outcomes and broader acceptance among both patients and healthcare professionals, ultimately pushing market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Innovation Matrix
  • Ecosystem of the Market
  • Regulatory Landscape
  • Technology Analysis
  • Patent Analysis
  • PESTEL Analysis
  • Market Attractiveness Index, 2023

Breast Reconstruction Market, By Product

  • Market Overview
  • Breast Implant
    • Silicone Implants
    • Round
    • Anatomical
    • Saline Implants
    • Round
    • Anatomical
  • Tissue Expander
    • Saline Tissue Expander
    • Air Tissue Expander
  • Acellular Dermal Matrix

Breast Reconstruction Market, By Procedure

  • Market Overview
  • Immediate Procedures
  • Delayed Procedures
  • Revision Procedures

Breast Reconstruction Market, By Type

  • Market Overview
  • Unilateral Breast Reconstruction
  • Bilateral

Breast Reconstruction Market, By End User

  • Market Overview
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Breast Reconstruction Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allergan Aesthetics (AbbVie) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ideal Implant Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sebbin (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GC Aesthetics (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • POLYTECH Health & Aesthetics (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sientra (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra Lifesciences (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RTI Surgical Holdings (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Establishment Labs S.A. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Silimed (Brazil)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratories Arion (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Guangzhou Wanhe Plastic Materials Co. Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CEREPLAS (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HansBiomed (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PMT Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai Kangning Medical Device (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biodermis (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Surgiform Technology, Ltd. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Motiva Implants (Costa Rica)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments